#112, Defeating the Diseases of Aging with Daniel Ives from Shift Bioscience

Imagine being able to reverse the biological clock and restore youth. That's the ambitious goal of Shift Bioscience, a biotech company pioneering novel gene-based cell rejuvenation therapies. In this episode of the AWS Health Innovation Podcast, Sanjit Misra from AWS hosts an in-depth conversation with Daniel Ives, the CEO and Founder of Shift Bioscience. Daniel's team has made significant breakthroughs in developing cell rejuvenation therapies using advanced cell simulation models and aging biomarkers to tackle the underlying driver of many age-related diseases.

1. How did Daniel Ives' research journey lead to the founding of Shift Bioscience?
• Daniel's path from studying mitochondrial mutations to founding Shift Bioscience illustrates a fascinating evolution in aging research. This transition underscores the potential for AI-driven approaches to revolutionize our understanding of cellular aging and rejuvenation.
2. What innovative approach does Shift Bioscience use to accelerate aging research?
• Shift Bioscience employs groundbreaking cell simulations that compress centuries of experiments into mere years. This approach enables rapid discovery of safe rejuvenation pathways, potentially fast-tracking the development of anti-aging therapies.
3. How does Shift Bioscience position itself in the field of longevity research?
• Operating at the cutting edge of longevity research, Shift Bioscience focuses on fundamental aging processes. Their work challenges conventional approaches, pushing the boundaries of what's possible in cellular rejuvenation and age-related disease prevention.
4. What is the significance of Shift Bioscience's single cell aging clock?
• The single cell aging clock represents a significant advancement in aging research. This machine learning-powered tool enables precise prediction of epigenetic age from single cell data, dramatically accelerating the pace of experimentation and discovery.
5. How does Shift Bioscience address the risks associated with cell rejuvenation?
• Shift Bioscience has discovered novel methods to rejuvenate cells without dangerous side effects. Their approach, including a single gene intervention, avoids the pluripotency risks associated with traditional Yamanaka factors, potentially offering safer anti-aging therapies.
6. How does cloud computing contribute to Shift Bioscience's research capabilities?
• By leveraging cloud computing, Shift Bioscience has revolutionized the speed and scale of aging experiments. Their ability to run hundreds of thousands of simulations in days demonstrates the power of combining biotechnology with advanced computing resources.

To learn more about Shift Bioscience and their groundbreaking work in cell rejuvenation, visit their website at https://www.shiftbioscience.com/.

Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.

Please take a moment and let us know what you think of the podcast, access our feedback survey here.